Literature DB >> 6636034

Mechanisms of vascular damage in gout and oxalosis: crystal induced, granulocyte mediated, endothelial injury.

M A Boogaerts, D E Hammerschmidt, C Roelant, R L Verwilghen, H S Jacob.   

Abstract

Immune triggered granulocyte (PMN)-endothelial interactions have been implicated in the pathogenesis of vascular diseases. While hyperuricemia and gout are associated with an increased risk of atherogenesis, we studied the modulation by monosodium-urate (MSU) crystals of PMN-endothelial interactions in vitro. The relationship between calcium oxalate (COX) crystals - implicated in the vasculitis of primary oxalosis - and immunologically mediated endothelial injury was also explored. Both MSU- and COX-crystal treated sera stimulate PMN to adhere to and induce significant 51Cr-release from endothelial cells in vitro. Platelets significantly increase crystal-triggered PMN endothelial cell adherence and 51Cr-release. This platelet augmenting effect depends on the release of platelet constituents (e.g. serotonin). Microcrystalline material present in vessel walls, thus may cause C-activation and may trigger PMN and platelets to damage endothelium in vitro and in vivo. These findings may have relevance to the understanding of the accelerated atherogenesis of hyperuricemia and the fulminant vasculitis of oxalosis or ethylene glycol poisoning.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6636034

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  9 in total

1.  Severity of gouty arthritis is associated with Q-wave myocardial infarction: a large-scale, cross-sectional study.

Authors:  Shih-Yang Chen; Ching-Lang Chen; Ming-Lai Shen
Journal:  Clin Rheumatol       Date:  2006-05-11       Impact factor: 2.980

2.  The mechanism of calcium oxalate crystal-induced haemolysis of human erythrocytes.

Authors:  J G Elferink
Journal:  Br J Exp Pathol       Date:  1987-08

3.  Mode of activation of the metabolic burst in polymorphonuclear leukocytes by calcium oxalate crystals.

Authors:  J G Elferink
Journal:  Agents Actions       Date:  1987-12

4.  Plasma oxalate concentration and secondary oxalosis in patients with chronic renal failure.

Authors:  C R Tomson; S M Channon; I S Parkinson; A R Morley; T W Lennard; N R Parrott; M F Laker
Journal:  J Clin Pathol       Date:  1988-10       Impact factor: 3.411

5.  Determinants of vascular function in patients with chronic gout.

Authors:  Robert D Brook; Srilakshmi Yalavarthi; James D Myles; Shokoufeh Khalatbari; Rita Hench; Susan Lustig; Wendy Marder; Adam Neidert; Mariana J Kaplan
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-12-22       Impact factor: 3.738

6.  High-sensitivity C-reactive protein and mean platelet volume in paediatric hypertension.

Authors:  Anna Wasilewska; Edyta Tenderenda; Katarzyna Taranta-Janusz; Walentyna Zoch-Zwierz
Journal:  Pediatr Nephrol       Date:  2010-04-23       Impact factor: 3.714

7.  Evaluation of disease activity in rheumatic patients by leucocyte adhesiveness/aggregation.

Authors:  S Berliner; M Fried; D Caspi; A Weinberger; M Yaron; J Pinkhas; M Aronson
Journal:  Ann Rheum Dis       Date:  1988-06       Impact factor: 19.103

8.  Evidence that serum calcium oxalate supersaturation is a consequence of oxalate retention in patients with chronic renal failure.

Authors:  E M Worcester; Y Nakagawa; D A Bushinsky; F L Coe
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

9.  Increased risk of vascular disease associated with gout: a retrospective, matched cohort study in the UK clinical practice research datalink.

Authors:  Lorna E Clarson; Samantha L Hider; John Belcher; Carl Heneghan; Edward Roddy; Christian D Mallen
Journal:  Ann Rheum Dis       Date:  2014-08-27       Impact factor: 19.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.